Trials / Conditions / Biphenotypic Acute Leukemia

Biphenotypic Acute Leukemia

9 registered clinical trials studyying Biphenotypic Acute Leukemia — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Child NCT06756152	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2 / Phase 3
Recruiting	BeFluBu vs FluBuRux Conditioning in Haploidentical HCT NCT06477549	St. Petersburg State Pavlov Medical University	Phase 2
Recruiting	Vitamin A and D Supplementation in Allogeneic HCT NCT06508099	St. Petersburg State Pavlov Medical University	Phase 2
Active Not Recruiting	Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Child NCT06475820	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2 / Phase 3
Recruiting	MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880	Medical College of Wisconsin	N/A
Recruiting	Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605	Masonic Cancer Center, University of Minnesota	Phase 2
Active Not Recruiting	Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibito NCT05515029	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 3
Completed	Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation NCT04942730	St. Petersburg State Pavlov Medical University	Phase 2
Completed	Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies NCT04191187	H. Lee Moffitt Cancer Center and Research Institute	Phase 2